(EDU) New Oriental Education - Overview
Exchange: NYSE •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US6475812060
Stock:
Total Rating 49
Risk 88
Buy Signal -0.86
| Risk 5d forecast | |
|---|---|
| Volatility | 47.2% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 4.27 |
| Character TTM | |
|---|---|
| Beta | 0.671 |
| Beta Downside | 0.631 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.79% |
| CAGR/Max DD | 0.13 |
EPS (Earnings per Share)
Revenue
Description: EDU New Oriental Education
New Oriental Education & Technology Group Inc. engages in the provision of private educational services under the New Oriental brand in the People's Republic of China. The company operates through four segments: Educational Services and Test Preparation Courses; Private Label Products and Livestreaming E-Commerce; Overseas Study Consulting Services; and Educational Materials and Distribution. The company offers test preparation courses to students taking language and entrance exams used by educational institutions in the United States, the Commonwealth countries, and the People's Republic of China. It also provides non-academic tutoring courses; intelligent learning systems and devices to offer a digital learning experience for students; and overseas studies consulting services. In addition, the company offers online education services through the Koolearn.com platform. Further, it develops and edits educational materials for language training and test preparation. In addition, the company offers educational programs, services, and products to students through schools; learning centers; and bookstores, as well as through its online learning platforms. New Oriental Education & Technology Group Inc. was founded in 1993 and is headquartered in Beijing, the People's Republic of China.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 381.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.98 > 1.0 |
| NWC/Revenue: 39.54% < 20% (prev 46.44%; Δ -6.90% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.11b > Net Income 381.1m |
| Net Debt (-1.06b) to EBITDA (686.6m): -1.55 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.5m) vs 12m ago -3.29% < -2% |
| Gross Margin: 55.33% > 18% (prev 0.53%; Δ 5480 % > 0.5%) |
| Asset Turnover: 64.59% > 50% (prev 63.11%; Δ 1.48% > 0%) |
| Interest Coverage Ratio: 1659 > 6 (EBITDA TTM 686.6m / Interest Expense TTM 311.0k) |
Altman Z'' 3.30
| A: 0.25 (Total Current Assets 5.59b - Total Current Liabilities 3.55b) / Total Assets 8.29b |
| B: 0.21 (Retained Earnings 1.77b / Total Assets 8.29b) |
| C: 0.06 (EBIT TTM 515.8m / Avg Total Assets 7.96b) |
| D: 0.54 (Book Value of Equity 2.19b / Total Liabilities 4.09b) |
| Altman-Z'' Score: 3.30 = A |
Beneish M -2.99
| DSRI: 0.98 (Receivables 42.9m/41.1m, Revenue 5.14b/4.82b) |
| GMI: 0.96 (GM 55.33% / 52.91%) |
| AQI: 1.24 (AQ_t 0.14 / AQ_t-1 0.11) |
| SGI: 1.07 (Revenue 5.14b / 4.82b) |
| TATA: -0.09 (NI 381.1m - CFO 1.11b) / TA 8.29b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of EDU shares?
As of March 01, 2026, the stock is trading at USD 54.65 with a total of 630,213 shares traded.
Over the past week, the price has changed by -9.29%, over one month by -2.36%, over three months by +6.86% and over the past year by +18.15%.
Over the past week, the price has changed by -9.29%, over one month by -2.36%, over three months by +6.86% and over the past year by +18.15%.
Is EDU a buy, sell or hold?
New Oriental Education has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy EDU.
- StrongBuy: 12
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EDU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.9 | 24.2% |
| Analysts Target Price | 67.9 | 24.2% |
EDU Fundamental Data Overview February 28, 2026
P/E Trailing = 23.225
P/E Forward = 14.0449
P/S = 1.8077
P/B = 2.3311
P/EG = 0.9893
Revenue TTM = 5.14b USD
EBIT TTM = 515.8m USD
EBITDA TTM = 686.6m USD
Long Term Debt = 14.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 262.1m USD (from shortTermDebt, last quarter)
Debt = 779.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.06b USD (from netDebt column, last quarter)
Enterprise Value = 8.23b USD (9.29b + Debt 779.9m - CCE 1.84b)
Interest Coverage Ratio = 1659 (Ebit TTM 515.8m / Interest Expense TTM 311.0k)
EV/FCF = 10.18x (Enterprise Value 8.23b / FCF TTM 808.0m)
FCF Yield = 9.82% (FCF TTM 808.0m / Enterprise Value 8.23b)
FCF Margin = 15.71% (FCF TTM 808.0m / Revenue TTM 5.14b)
Net Margin = 7.41% (Net Income TTM 381.1m / Revenue TTM 5.14b)
Gross Margin = 55.33% ((Revenue TTM 5.14b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Gross Margin QoQ = 53.26% (prev 58.12%)
Tobins Q-Ratio = 0.99 (Enterprise Value 8.23b / Total Assets 8.29b)
Interest Expense / Debt = 0.04% (Interest Expense 311.0k / Debt 779.9m)
Taxrate = 30.30% (24.5m / 80.9m)
NOPAT = 359.5m (EBIT 515.8m * (1 - 30.30%))
Current Ratio = 1.57 (Total Current Assets 5.59b / Total Current Liabilities 3.55b)
Debt / Equity = 0.20 (Debt 779.9m / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = -1.55 (Net Debt -1.06b / EBITDA 686.6m)
Debt / FCF = -1.32 (Net Debt -1.06b / FCF TTM 808.0m)
Total Stockholder Equity = 3.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.79% (Net Income 381.1m / Total Assets 8.29b)
RoE = 10.04% (Net Income TTM 381.1m / Total Stockholder Equity 3.80b)
RoCE = 13.53% (EBIT 515.8m / Capital Employed (Equity 3.80b + L.T.Debt 14.4m))
RoIC = 9.45% (NOPAT 359.5m / Invested Capital 3.80b)
WACC = 7.74% (E(9.29b)/V(10.07b) * Re(8.39%) + D(779.9m)/V(10.07b) * Rd(0.04%) * (1-Tc(0.30)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 72.51% ; FCFF base≈721.8m ; Y1≈498.0m ; Y5≈250.9m
[DCF] Fair Price = 38.51 (EV 5.06b - Net Debt -1.06b = Equity 6.13b / Shares 159.1m; r=7.74% [WACC]; 5y FCF grow -36.32% → 2.90% )
EPS Correlation: 49.51 | EPS CAGR: 133.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.60 | Revenue CAGR: 19.40% | SUE: 0.66 | # QB: 0
EPS current Year (2026-05-31): EPS=3.57 | Chg7d=+0.000 | Chg30d=+0.131 | Revisions Net=+12 | Growth EPS=+12.7% | Growth Revenue=+11.5%
EPS next Year (2027-05-31): EPS=4.23 | Chg7d=+0.000 | Chg30d=+0.245 | Revisions Net=+14 | Growth EPS=+18.4% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +0.86 (13 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 8.4% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.7% (Analyst 10.8% - Implied 4.1%)
P/E Forward = 14.0449
P/S = 1.8077
P/B = 2.3311
P/EG = 0.9893
Revenue TTM = 5.14b USD
EBIT TTM = 515.8m USD
EBITDA TTM = 686.6m USD
Long Term Debt = 14.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 262.1m USD (from shortTermDebt, last quarter)
Debt = 779.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.06b USD (from netDebt column, last quarter)
Enterprise Value = 8.23b USD (9.29b + Debt 779.9m - CCE 1.84b)
Interest Coverage Ratio = 1659 (Ebit TTM 515.8m / Interest Expense TTM 311.0k)
EV/FCF = 10.18x (Enterprise Value 8.23b / FCF TTM 808.0m)
FCF Yield = 9.82% (FCF TTM 808.0m / Enterprise Value 8.23b)
FCF Margin = 15.71% (FCF TTM 808.0m / Revenue TTM 5.14b)
Net Margin = 7.41% (Net Income TTM 381.1m / Revenue TTM 5.14b)
Gross Margin = 55.33% ((Revenue TTM 5.14b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Gross Margin QoQ = 53.26% (prev 58.12%)
Tobins Q-Ratio = 0.99 (Enterprise Value 8.23b / Total Assets 8.29b)
Interest Expense / Debt = 0.04% (Interest Expense 311.0k / Debt 779.9m)
Taxrate = 30.30% (24.5m / 80.9m)
NOPAT = 359.5m (EBIT 515.8m * (1 - 30.30%))
Current Ratio = 1.57 (Total Current Assets 5.59b / Total Current Liabilities 3.55b)
Debt / Equity = 0.20 (Debt 779.9m / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = -1.55 (Net Debt -1.06b / EBITDA 686.6m)
Debt / FCF = -1.32 (Net Debt -1.06b / FCF TTM 808.0m)
Total Stockholder Equity = 3.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.79% (Net Income 381.1m / Total Assets 8.29b)
RoE = 10.04% (Net Income TTM 381.1m / Total Stockholder Equity 3.80b)
RoCE = 13.53% (EBIT 515.8m / Capital Employed (Equity 3.80b + L.T.Debt 14.4m))
RoIC = 9.45% (NOPAT 359.5m / Invested Capital 3.80b)
WACC = 7.74% (E(9.29b)/V(10.07b) * Re(8.39%) + D(779.9m)/V(10.07b) * Rd(0.04%) * (1-Tc(0.30)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 72.51% ; FCFF base≈721.8m ; Y1≈498.0m ; Y5≈250.9m
[DCF] Fair Price = 38.51 (EV 5.06b - Net Debt -1.06b = Equity 6.13b / Shares 159.1m; r=7.74% [WACC]; 5y FCF grow -36.32% → 2.90% )
EPS Correlation: 49.51 | EPS CAGR: 133.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.60 | Revenue CAGR: 19.40% | SUE: 0.66 | # QB: 0
EPS current Year (2026-05-31): EPS=3.57 | Chg7d=+0.000 | Chg30d=+0.131 | Revisions Net=+12 | Growth EPS=+12.7% | Growth Revenue=+11.5%
EPS next Year (2027-05-31): EPS=4.23 | Chg7d=+0.000 | Chg30d=+0.245 | Revisions Net=+14 | Growth EPS=+18.4% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +0.86 (13 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 8.4% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.7% (Analyst 10.8% - Implied 4.1%)